Weild David's most recent trade in Biosig Technologies Inc was a trade of 16,000 Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Biosig Technologies Inc | Weild David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 16,000 | 114,999 (0%) | 0% | 0 | Common Stock | |
Biosig Technologies Inc | David Weild | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 17,544 | 98,999 (0%) | 0% | 0 | Common Stock | |
Biosig Technologies Inc | David Weild | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 16,000 | 81,455 (0%) | 0% | 0 | Common Stock | |
Biosig Technologies Inc | David Weild | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 45,455 | 65,455 (0%) | 0% | 0 | Common Stock | |
PAVmed Inc | David Weild | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) |